论文部分内容阅读
目的评价布拉氏酵母菌在治疗儿童急性腹泻中的作用及安全性。方法将120例急性腹泻患者随机分为2组,每组60例,对照组采用双歧杆菌三联活菌散加双八面体蒙脱石,治疗组采用布拉酵母菌,观察其疗效。结果两组在治疗后48 h大便好转数、治疗后72 h痊愈数、治疗5 d后大便减少次数、止泻时间、病程<7 d比率方面效果相当(P>0.05)。结论布拉氏酵母菌治疗急性腹泻的疗效等同于双歧杆菌三联活菌散加双八面体蒙脱石,并且未观察到不良反应。
Objective To evaluate the role and safety of Blah’s yeast in the treatment of children with acute diarrhea. Methods A total of 120 patients with acute diarrhea were randomly divided into two groups (n = 60 in each group). The control group was treated with bifidobacterium and boctahedral montmorillonite. Results The number of stools recovered at 48 h after treatment, the number of healed at 72 h after treatment, the frequency of stool reduction, antidiarrheal time and the duration of disease less than 7 d after treatment for 5 days were comparable (P> 0.05). Conclusion The curative effect of B. burgdorferi in the treatment of acute diarrhea is equivalent to that of bifidobacterium triplet plus dioctahedral smectite, and no adverse reactions were observed.